|
| 37501549 | Children's Oncology Group's 2023 blueprint for research: Bone tumors. | Pediatr Blood Cancer | 2023 |
| 36302496 | Analysis of Local Control Outcomes and Clinical Prognostic Factors in Localized Pelvic Ewing Sarcoma Patients Treated With Radiation Therapy: A Report From the Children's Oncology Group. | Int J Radiat Oncol Biol Phys | 2023 |
| 35920604 | Comment on: Clinical, pathologic, and molecular features of inflammatory myofibroblastic tumors in children and adolescents: ROS1-fusion inflammatory myofibroblastic tumor: ROS1-fusion inflammatory myofibroblastic tumor. | Pediatric Blood and Cancer | 2023 |
| 37596911 | Loss of heterozygosity does not occur in BRCA1/2 mutant pediatric solid and central nervous system tumors. | Pediatr Blood Cancer | 2023 |
| 37920939 | Innovations in Cancer Treatment of Children. | | 2023 |
| 37651654 | Long-Term Outcomes in Patients With Localized Ewing Sarcoma Treated With Interval-Compressed Chemotherapy on Children's Oncology Group Study AEWS0031. | J Clin Oncol | 2023 |
| 37644664 | Evaluation of prevalence and outcomes of serial tyrosine kinase inhibitor use in pediatric patients with advanced solid tumors. | | 2023 |
| 37715723 | Phase 1 study of cabozantinib in combination with topotecan-cyclophosphamide for patients with relapsed Ewing sarcoma or osteosarcoma. | | 2023 |
| 37956387 | Osteosarcoma Explorer: A Data Commons With Clinical, Genomic, Protein, and Tissue Imaging Data for Osteosarcoma Research. | JCO Clin Cancer Inform | 2023 |
| 37267580 | The Childhood Cancer Data Initiative: Using the Power of Data to Learn From and Improve Outcomes for Every Child and Young Adult With Pediatric Cancer. | J Clin Oncol | 2023 |
| 37264747 | A single-institution pediatric and young adult interventional oncology collaborative: Novel therapeutic options for relapsed/refractory solid tumors. | Cancer Med | 2023 |
| 37057373 | Clear cell tumor with melanocytic differentiation and MITF::CREM translocation. | | 2023 |
| 36996377 | Clinical Targeted Next-Generation Panel Sequencing Reveals <i>MYC</i> Amplification Is a Poor Prognostic Factor in Osteosarcoma. | JCO Precis Oncol | 2023 |
| 37369988 | A pooled subgroup analysis of glucarpidase treatment in 86 pediatric, adolescent, and young adult patients receiving high-dose methotrexate therapy in open-label trials. | | 2023 |
| 36861440 | Genomic analysis reveals germline and somatic PDGFRB variants with clinical implications in familial infantile myofibromatosis. | | 2023 |
| 36791345 | Priorities to Promote Participant Engagement in the Participant Engagement and Cancer Genome Sequencing (PE-CGS) Network. | Cancer Epidemiol Biomarkers Prev | 2023 |
| 37228094 | Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C. | J Natl Cancer Inst | 2023 |
| 36724495 | Joint Adult and Pediatric Working Group as a Successful Platform to Strengthen Adolescent and Young Adult (AYA) Clinical Trial Collaboration: A Report from the NCTN/SARC AYA Clinical Trials Sarcoma Working Group. | | 2023 |
| 36669140 | Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncology Group. | J Clin Oncol | 2023 |
| 35347250 | Rapid and highly sensitive approach for multiplexed somatic fusion detection. | Modern Pathology | 2022 |
| 35512711 | Germline predisposition to pediatric Ewing sarcoma is characterized by inherited pathogenic variants in DNA damage repair genes. | Am J Hum Genet | 2022 |
| 36221002 | Adverse prognostic impact of the loss of STAG2 protein expression in patients with newly diagnosed localised Ewing sarcoma: A report from the Children's Oncology Group. | Br J Cancer | 2022 |
| 36347760 | Erratum to 'Linking EORTC QLQ-C-30 and PedsQL/PEDQOL physical functioning scores in patients with osteosarcoma' [Eur J Cancer 170 (2022) 209-235]. | Eur J Cancer | 2022 |
| 35689897 | Linking EORTC QLQ-C-30 and PedsQL/PEDQOL physical functioning scores in patients with osteosarcoma. | Eur J Cancer | 2022 |
| 35809374 | Phase 2 study of anti-disialoganglioside antibody, dinutuximab, in combination with GM-CSF in patients with recurrent osteosarcoma: A report from the Children's Oncology Group. | Eur J Cancer | 2022 |
| 35739269 | Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer. | Nat Med | 2022 |
| 35484995 | <sup>68</sup> Ga-DOTATATE PET and functional imaging in pediatric pheochromocytoma and paraganglioma. | Pediatr Blood Cancer | 2022 |
| 35731997 | Gamma Secretase Inhibition for a Child With Metastatic Glomus Tumor and Activated NOTCH1. | JCO Precision Oncology | 2022 |
| 35363510 | Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial. | J Clin Oncol | 2022 |
| 35863108 | Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration. | Eur J Cancer | 2022 |
| 35543076 | Histologic characterization of paediatric mesenchymal neoplasms treated with kinase-targeted therapy. | Histopathology | 2022 |
| 35353553 | Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial. | J Clin Oncol | 2022 |
| 36446043 | Rare FGFR Oncogenic Alterations in Sequenced Pediatric Solid and Brain Tumors Suggest FGFR Is a Relevant Molecular Target in Childhood Cancer. | JCO Precis Oncol | 2022 |
| 36187937 | BRCA1-associated RING domain-1 (BARD1) loss and GBP1 expression enhance sensitivity to DNA damage in Ewing sarcoma. | Cancer Res Commun | 2022 |
| 36115869 | An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma. | NPJ Precis Oncol | 2022 |
| 36585406 | Author Correction: Osteosarcoma. | Nat Rev Dis Primers | 2022 |
| 36481668 | Osteosarcoma. | Nat Rev Dis Primers | 2022 |
| 34515544 | Identified Enrollment Challenges of Adolescent and Young Adult Patients on the Nonchemotherapy Arm of Children's Oncology Group Study ARST1321. | Journal of Adolescent and Young Adult Oncology | 2022 |
| 35235382 | Reply to J.-G. Wang et al. | Journal of Clinical Oncology | 2022 |
| 34814185 | Molecular Characterization of Inflammatory Tumors Facilitates Initiation of Effective Therapy. | Pediatrics | 2021 |
| 33751835 | Retrospective evaluation of single patient investigational new drug (IND) requests in pediatric oncology. | Cancer Med | 2021 |
| 33625877 | OncoTree: A Cancer Classification System for Precision Oncology. | JCO Clin Cancer Inform | 2021 |
| 34099491 | Gene Fusions Create Partner and Collateral Dependencies Essential to Cancer Cell Survival. | Cancer Res | 2021 |
| 33563661 | Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory, or High-Risk Leukemias: A Report from the LEAP Consortium. | Cancer Discov | 2021 |
| 33507338 | Extrapolation of pharmacokinetics and pharmacodynamics of sunitinib in children with gastrointestinal stromal tumors. | Cancer Chemotherapy and Pharmacology | 2021 |
| 33769463 | Patterns of Translocation Testing in Patients Enrolling in a Cooperative Group Trial for Newly Diagnosed Metastatic Ewing Sarcoma. | Arch Pathol Lab Med | 2021 |
| 34137164 | Charting a path for prioritization of novel agents for clinical trials in osteosarcoma: A report from the Children's Oncology Group New Agents for Osteosarcoma Task Force. | Pediatr Blood Cancer | 2021 |
| 34325058 | Assessment of BCOR Internal Tandem Duplications in Pediatric Cancers by Targeted RNA Sequencing. | Journal of Molecular Diagnostics | 2021 |
| 33314665 | A case of metastatic adenocarcinoma of unknown primary in a pediatric patient: Opportunities for precision medicine. | Pediatr Blood Cancer | 2021 |
| 33258278 | Derivation and validation of risk groups in patients with osteosarcoma utilizing regression tree analysis. | Pediatric Blood and Cancer | 2021 |